WFS1 Gene Wolfram-like Syndrome Autosomal Dominant Genetic Test in UAE

Executive Summary & Core Metrics

Accuracy Guarantee: 99.9% Analytical Sensitivity for single nucleotide variants and small insertions/deletions via ISO‑certified NGS workflow.
Premium Logistics: Paid hospital‑grade home collection with dedicated cold‑chain transport and VIP mobile phlebotomy service across all Emirates.
Clinical Guidance: Complimentary telephonic post‑test clinical discussion of results and their implications with our genetic counselling team.
Insurance: Direct billing verification – send your policy card via WhatsApp +971 54 548 8731.

Test Overview & Methodology

This advanced genetic test uses Next‑Generation Sequencing to analyse the entire WFS1 gene for mutations linked to autosomal dominant Wolfram‑like syndrome, which can cause sensorineural hearing loss, optic atrophy, and endocrine disturbances.

The NGS workflow includes full coverage of all coding exons and flanking intronic regions, plus detection of copy number variants (deletions/duplications) that Sanger sequencing alone would miss.

Parameter	Our Test – WFS1 NGS (CE‑Marked)	Closest Alternative – Single Gene Sanger
Methodology	Next‑Generation Sequencing + CNV detection	Sanger sequencing only
Variant Coverage	100% coding exons ± 10 bp, intragenic deletions/duplications	Selected exons only; CNVs missed
Turnaround Time	3–4 weeks	4–6 weeks
Pre‑ & Post‑Test Genetic Counselling	Included (Arabic/English)	Often additional cost
Insurance Support	Direct billing verification + reimbursement assistance	Manual claims only

Physician Insight & Safety Protocols

“Genetic testing provides clarity, yet every result must be correlated with your personal and family medical history. I advise all patients to use this test as a guide, not a standalone verdict, and to always involve a specialist in interpreting the findings.”

— Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA Registration ID: 9294403

Medication Advisory

Medication Warning

Do not discontinue any prescribed medication (e.g., insulin, desmopressin, hearing aids) without first consulting your treating physician.

Exclusion Criteria & Emergency Red Flags

Exclusion: Inability to provide a blood sample or FTA card; no clinical indication for WFS1‑related disorder; minors without parental consent and mandatory genetic counselling under Federal Decree-Law No. 4 of 2016 on Medical Liability.
ER Red Flags: Sudden, severe vision loss or acute hearing loss; signs of severe dehydration and hypernatremia from diabetes insipidus; uncontrolled diabetes mellitus with ketosis. Seek immediate medical attention.

Patient FAQ & Clinical Guidance

1. What does the WFS1 gene test detect?

This genetic test identifies pathogenic variants in the WFS1 gene responsible for autosomal dominant Wolfram‑like syndrome.

2. Who should consider this test?

Individuals with unexplained sensorineural hearing loss, optic atrophy, and early‑onset diabetes or diabetes insipidus should consider WFS1 testing.

3. How long does it take to get results?

Results are available within 3 to 4 weeks from sample receipt at our ISO‑certified laboratory.

UAE Regulatory & Data Privacy Adherence

Your Data, Your Rights

This test is conducted under the Dubai Healthcare City (DHCC) regulatory framework and complies with:

Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL)
Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields
Federal Decree-Law No. 4 of 2016 on Medical Liability (for clinical safety and informed consent)
DHA Facility License No. 1143 – Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE

All genetic data is stored on encrypted servers, access is restricted to authorized personnel, and results are shared only with the patient and their consulting physician.

Clinical & Logistical Metadata

Test Name	WFS1 Gene Wolfram-like Syndrome Autosomal Dominant Genetic Test
Price (AED)	AED 2,800
Turnaround Time	3–4 weeks
Sample Type / Matrix	Peripheral whole blood (EDTA) or FTA card (dried blood spot)
Methodology Used	Next‑Generation Sequencing (NGS) with CNV detection
ICD-10-CM Code	E13.8
LOINC Code	82161-3
DHA Facility License & Laboratory Address	DNA Labs UAE — License No. 1143, Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE